*By Brian Henry*
Even as British Prime Minister Theresa May suffered an embarrassing defeat as her Brexit vote was voted down in Parliament, and then only narrowly survived a no-confidence vote, investors remained relatively unrattled.
According to Chris Demetriou, the U.S. CEO at Aberdeen Standard Investments, the mild response to the vote was not a surprise.
"There are two elements to it," he told Cheddar Wednesday.
"The vote \[Tuesday\] and the no confidence vote \[Wednesday\] weren't really a surprise to anybody. It's long been speculated Theresa May didn't have the votes to carry the deal through Parliament."
Demetriou said that the decision by British lawmakers to reject the Brexit deal by such a historic margin ー 432 to 202 ーearlier this week actually has investors feeling confident.
"The resounding defeat, the size of the defeat, really suggests that a tweak to the deal probably isn't going to help get it through either. I think that, perhaps, is giving investors confidence that the can will be kicked down the road or potentially even a more formal withdrawal of Article 15."
"Investors want as a little change as possible in the current arrangement," he added.
Demetriou says productive trade talks between the U.S. and China as well as the Federal Reserve displaying patience on future rate hikes have led to less market volatility.
"A lot of the uncertainty we saw in the back end of the year, the escalation of trade discussions, perhaps concern around fed policy coming into 2019 ー a lot of that has reversed in the beginning of January."
But will the relative market peace last?
"There's a lot of positive news or certainly constructive news out there to offset some of the uncertainty that exists," Demetriou said.
"We do expect continued uncertainty, which breeds volatility in the markets and that will continue throughout the year."
For full interview [click here](https://cheddar.com/videos/the-uk-government-survives-no-confidence-vote-after-brexit-defeat).
Stocks turned lower Friday on Wall Street after New York became the latest major state to mandate nearly all workers stay home to limit the spread of the new coronavirus.
Senator Richard Burr (R-N.C.) is under intense scrutiny after an NPR report showed that he revealed the severity of the impending coronavirus crisis to a group of North Carolinians in private and warned of major life disruptions weeks before the federal government did the same. And, as the coronavirus outbreak continues to wreak havoc on supply chains, hospitals and markets, new financial disclosures show that Burr made big money moves before the indices showed the historic declines seen in recent weeks.
More than 60 percent of Americans also think a recession will come in the next year, according to a new study by YouGov.
Trump’s coronavirus task force on Thursday afternoon visited the Federal Emergency Management Agency to hear from several governors about the challenges facing their states.
In the morning conference, the governor also waived mortgage payments for 90 days and revealed the spike in new cases bringing the full total to 4,152, the most in the nation.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
Coronavirus has hit Capitol Hill, as the first members of Congress have tested positive for the virus. Reps. Mario Diaz-Balart (R-Fla.) and Ben McAdams (D-Utah) announced diagnoses late Wednesday.
The palace of Monaco says its head of state, Prince Albert II, has tested positive for the new coronavirus. In a statement Thursday, the palace of the tiny Mediterranean principality said that his health is not worrying.
GM and Tesla are among the top U.S. automakers that are looking to potentially switch over stalled auto production into the manufacturing of badly needed medical ventilators amid the coronavirus crisis.
Rep. Gabbard drops out of the Democratic presidential primary race and endorses former Vice President Joe Biden.
